A mercury sphygmomanometer for home use can be used to measure blood pressure and guide blood pressure control. Can a mercury sphygmomanometer for home use also prevent strokes? The principle of using a mercury sphygmomanometer to prevent stroke is called remote ischemic preadaptation, which protects against cerebral ischemia. Remote ischemic pre-adaptation is the protection of some organs of the body (e.g. upper limbs) against subsequent severe or fatal ischemia and hypoxia by inducing other organs than the ischemic organ (e.g. heart, brain, liver, kidney) after a brief, reversible ischemic and hypoxic stimulus. For example, if you normally need to eat two bowls of rice to get full, after this training, your body gradually adapts to eat one bowl of rice and feel less hungry. Even if you have to go hungry for a few days, you will be able to tolerate hunger better than others. Remote ischemic preadaptation therapy is not only effective before severe ischemia, but also when severe ischemia occurs, and after severe ischemia occurs, it can also produce the effect of reducing the injury and improving the prognosis. The therapy can control or reduce the occurrence of cerebral ischemic events (such as dizziness, limb numbness, hemiparesis, etc.), improve the blood flow to the brain tissue in the ischemic area so that the blood flow meets the metabolic needs and helps to improve the symptoms. In other words, patients who are usually treated with this method can effectively prevent the occurrence of ischemic stroke, and even if they still have a stroke attack, they can tolerate ischemia and hypoxia for a longer period of time than others and have a smaller infarct area, which can buy more time and opportunities for further interventional treatment. This technique has been applied to treat more than thousands of patients with cerebral ischemia. Through years of follow-up, the frequency and degree of transient ischemic attacks have improved with a 95.2% improvement in cerebral blood flow and cerebral metabolism in patients’ follow-up complaints. Remote ischemic pre-habilitation training is effective and is a new proven treatment method. It has been published in the international well-known cerebrovascular disease journal “neurology” and has received wide attention both at home and abroad. The research results generated will promote the rapid development of neuroscience in China for the benefit of patients with cerebrovascular disease in the country and even in Asia. Therefore, the smart use of blood pressure meter can effectively prevent and control stroke. Indications Patients with a family history of triple high and cardiovascular disease, middle-aged or older people with high-risk factors, those who are unwilling or unable to tolerate surgical treatment, and patients with smog, young stroke or other unexplained cerebrovascular stenosis or occlusion, manifesting as dizziness and stuffy discomfort, are suitable for this method. Method Using a sphygmomanometer, do this twice a day 1. The patient is placed in a lying or semi-sitting position with both upper limbs at the same level as the heart. 2.Wrap the mercury sphygmomanometer cuff around the middle and upper part of the upper arm on one side, and pressurize the balloon to 180~220mmHg, maintain it for 5 minutes, then release the balloon pressure to rest for 5 minutes for one round. 3. Repeat 5 rounds consecutively for a total of 50 minutes each time, twice a day. It is recommended to do it once in the morning and once in the afternoon, alternating with bilateral upper limbs. 4.6 months is a course of treatment. Evaluation The prevention and treatment of ischemic cerebrovascular disease must control blood pressure, blood sugar and blood lipids, quit smoking and alcohol, change dietary habits and strengthen exercise in addition to remote ischemic pre-habilitation training. Remote ischemic preadaptation training is effective, simple and risk-free, and is well received by patients. This method is unique for the treatment of small and medium-sized vascular lesions because it requires no hospitalization, no surgical risk, stable effect, no attenuation, and no lifelong treatment. This treatment method is endogenous, which means that the body’s own defense and repair functions are mobilized for the purpose of prevention and treatment of cerebral ischemia.